What Are Recombinant Antibodies?
Recombinant antibodies are produced from defined DNA sequences, enabling precise control over antibody structure, species, and functional properties. In preclinical research, this approach supports reproducibility and reduces variability that can arise from long-term hybridoma culture. Because the antibody sequence is fixed, recombinant antibodies provide a consistent foundation for studies that span experiments, models, or research teams.
Why Recombinant Antibodies Matter in In Vivo Studies
In vivo optimized recombinant antibodies are engineered to deliver consistent performance.
Traditional hybridoma-derived antibodies are produced from living cell lines, which can exhibit subtle variation over extended culture and use.
Bio X Cell recombinants are engineered on in vivo–optimized IgG backbones designed for functional performance in depletion and immune-modulation studies. This approach ensures consistency, experimental continuity, and reliable performance across the life of a research program.
Why Recombinant Formats Help
Sequence-defined reproducibility
Stable performance across batches
Flexible formats with preserved target specificity
Common Research Scenarios
Longitudinal studies over extended timeframes
Multi-site or multi-team research programs
Cross-model comparisons requiring high consistency
Built-In Control Through Recombinant Production
A defined antibody sequence supports consistent structure and functional behavior.
Recombinant antibodies are generated by cloning defined antibody genes into controlled expression systems rather than relying on continuously cultured hybridoma cells. This approach separates antibody performance from long-term cell line behavior and allows key characteristics to be specified intentionally.
Because the antibody sequence is fixed and known, recombinant production supports consistent reproduction of the same molecule over time. This level of control is particularly valuable in studies that require repeatability across experiments, teams, or extended research timelines.
What recombinant production controls:
→ Antibody sequence definition
→ Expression system consistency
→ Reproducible molecular structure
→ Stable performance across batches
Designing Antibodies for the Right Biological Context
Recombinant formats allow antibody properties to be aligned with experimental context
Traditional hybridoma-derived antibodies are produced from living cell lines, which can exhibit subtle variation over extended culture and use. Recombinant antibodies provide a sequence-defined alternative by fixing the antibody sequence at the DNA level, enabling consistent reproduction of the same molecule when needed. This approach supports continuity across experiments and over the life of a research program.
Species and Isotype Considerations
Species and isotype influence antibody behavior in model systems. Recombinant antibodies can be produced with defined constant regions to match the experimental context and support consistent interpretation across studies.
Fc Properties
Fc interactions can affect biological responses depending on study design. Recombinant production allows Fc properties to be defined in advance, supporting clearer interpretation of target-driven effects.
Quality and Formulation Considerations
Antibody formulation, including purity and endotoxin levels, can affect experimental readouts, particularly in in vivo and advanced in vitro models.
Defined quality attributes help support consistent performance and reduce unintended background effects. Formulation considerations are especially relevant when studies span multiple experiments or when biological systems are sensitive to trace impurities.
RecombiMAb™ Antibody Features
Consistent and Reproducible Performance
RecombiMAb™ antibodies are produced from defined DNA sequences encoding a single heavy and light chain pair, supporting consistent antibody structure and performance across production lots.
Species Matching Chimerization
RecombiMAb™ antibodies are available with mouse or human IgG constant regions, supporting use in mouse or humanized mouse models where species-matched Fc regions are relevant.
Fc Effector Function Modulation
Select RecombiMAb™ antibodies are available with modified Fc regions to support studies where Fc-mediated effector activity is not desired. Available options include Fc-silencing mutations such as D265A, S228P, and LALA-PG.
Select RecombiMAb™ antibodies are available in multiple Fc-silenced versions. These Fc silenced versions have mutations in the antibody’s Fc fragment, rendering them unable to bind to endogenous Fcγ receptors or complement in vivo, thereby eliminating Fc-mediated antibody effector functions. Available Fc silencing mutations include D265A, S228P, and LALA-PG.
Formulated for in vivo Use
RecombiMAb™ antibodies are provided in carrier-free formulations appropriate for in vivo studies, without preservatives or stabilizing proteins that may interfere with biological interpretation.
Binding Confirmation
Each RecombiMAb™ product undergoes defined binding confirmation to support confidence in antigen recognition.
Ultra-low Endotoxin Levels
RecombiMAb™ antibodies are produced with controlled endotoxin levels, with QC testing performed on each lot. Products are typically ≤1 EU/mg, with lower levels available upon request.
Pathogen Screening
Each RecombiMAb™ product is screened for murine pathogens, with results provided in product-specific datasheets to support animal facility requirements.
Low Protein Aggregation
RecombiMAb™ antibodies are QC-tested for aggregation levels, supporting consistent performance in sensitive experimental systems.
Meet Our Leaders
Learn more about the team behind the gold standard in vivo antibodies.
Discover Bio X Cell
Learn more about our proven expertise and comprehensive antibody solutions.
See Our Impact
Discover the Bio X Cell Fund’s mission to improve the health of our community
Explore Our Latest
See our latest articles and whitepapers for scientific insights and ideas
Consult With Bio X Cell to Enable Your Next Breakthrough Discovery
Whether you need antibody customization or high-volume production, Bio X Cell is committed to advancing your therapeutic innovations.
Contact Us